Figure 1
From: ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside
The chemical structure of ABT-869: N- [4-(3-amino-1H-indazol-4-yl)phenyl]- N1-(2-fluoro-5-methylphenyl) urea.
Figure 1 | Journal of Hematology & Oncology